Minimally Invasive/Non-Invasive Surgery Market Research Reports & Consulting

Market Reports

• Bone Growth Stimulator Market by Product (Device (Implant, External), Bone Morphogenetic Protein, PRP), Application (Spinal Fusion, Delayed Union, Non-union Bone Fracture, Maxillofacial Surgery), Care Setting (Hospital, Homecare) (2022 - 2026)

  The global Bone growth stimulator market is expected to grow from USD 1.1 billion in 2021 to USD 1.5 billion by 2026, at a compound annual growth rate (CAGR) of 5.8% during the forecast period.Orthofix Medical, Inc. (US), DJO Finance, LLC (US), Zimmer Biomet (US), Bioventus LLC (US), Medtronic plc (Ireland), Stryker (US), DePuy Synthes (US), Arthrex, Inc. (US), Isto Biologics (US), Terumo Corporation (Japan), Ember Therapeutics, Inc. (US), Ossatec Benelux Ltd. (Netherlands), Altis Biologics (Pty) Ltd. (South Africa), Regen Lab SA (Switzerland), ITO Co., Ltd. (Japan), Elizur Corporation (US), BTT Health GmbH (Germany), Stimulate Health Inc. (Canada), VQ OrthoCare (US), Kinex Medical Company, LLC (US), Fintek Bio-Electric Inc. (Canada), Biomedical Tissue Technologies Pty Ltd. (Germany), T-Biotechnology (Turkey), DrPRP America LLC (US), Ivy Sports Medicine, LLC (US), Glofinn Oy (Finland), and REMI GROUP (India)

  • Published: July 2021
  • Price: $ 4950
  • TOC Available:

• Tumor Ablation Market by Technology (Radiofrequency, Microwave, Cryoablation, IRE, Ultrasound, Laser), Mode of Treatment (Surgical, Laparoscopic, Percutaneous), Application (Liver, Lung, Kidney, Bone Metastasis, Prostate, Breast) - Global Forecast 2021

  The global tumor ablation market is estimated to grow at a CAGR of 12.5% to reach USD 580.1 Million by 2021. Technological advancements in the field of tumor ablation coupled with increased procedural safety profile, rising market demand of minimal invasive tumor ablation techniques, increasing prevalence of cancer across the globe, as well as growing number of public-private initiatives & funding to support ongoing research activities related to tumor ablation are propelling the growth of the market. Over the past three years, the company has adopted new product launches, product enhancements, and geographic expansion as its key business strategies to ensure its dominance in this market. Angiodynamics, Inc. (U.S.), Boston Scientific Corporation (U.S.), Galil Medical, Inc. (U.S.), EDAP TMS S.A. (France), Healthtronics, Inc. (U.S.), Medtronic, Plc (U.S.), Mermaid Medical, Inc. (Denmark), Mesonix, Inc. (U.S.), Neuwave Medical, Inc. (U.S.) and Sonacare Medical, LLC (U.S.) are some of the other key players operating in the tumor ablation market.

  • Published: October 2016
  • Price: $ 4950
  • TOC Available:

• Varicose Vein Treatment Market by Products (Laser & RF Ablation, Venous Closure, Surgical), Treatment Mode (Endovenous Ablation, Sclerotherapy, Stripping), Region (North America, Europe) - Forecasts to 2021

  The varicose vein treatment market is expected to reach $289.7 million by 2021 from $207.9 million in 2016, at a CAGR of 6.9% between 2016 and 2021. The swollen, twisted veins that are visible under the skin are termed as varicose veins.

  • Published: May 2016
  • Price: $ 4950
  • TOC Available:

• Minimally Invasive Medical Robotics, Imaging & Visualization Systems & Surgical Instruments Market Forecasts to 2016 (DA VINCI, Robodoc, Spine Assist, Neuromate, Ultrasound, CT, MRI, X-RAY Imaging, Electrosurgical Devices,  Handheld Instruments, Guiding Devices, Inflation Systems & Auxiliary Devices) Global Trends & Competitive Analysis

  A minimally invasive surgical (MIS) procedure refers to the surgery performed with minute incisions in the body; for instance, plaque blockages in the arteries of the heart and other vessel walls of peripheral organs, such as lower extremities, neck, kidneys, and brain. The principal advantage of these procedures over surgery is short recovery time, small scars, low risk of infection, less bleeding, and shorter hospital stays.

  • Published: July 2012
  • Price: $ 4950
  • TOC Available:

• Global Minimally Invasive Surgery Market 2010 - 2015

  The global minimally invasive surgery market is witnessing steady growth due to rapid technological advancements changing demographics and rising awareness amongst the patient population for less invasive procedures or single incision procedures.

  • Published: October 2010
  • Price: $ 4950
  • TOC Available:

• Minimally Invasive and Non Invasive Product and Service Market (2009 - 2014)

  This report will analyze the market potential for minimally invasive/non-invasive surgery. The target segment (end-users) of the minimal invasive/non-invasive surgery products are mainly hospital surgical departments, outpatient surgery centers, group medical practices, individual surgeons, and medical schools. The number of outpatient centers is set to rise, as a low cost alternative for hospitals.

  • Published: July 2009
  • Price: $ 4950
  • TOC Available: